Scandinavian ChemoTech AB Series B Cash Flow Reinvestment Rate
Scandinavian ChemoTech AB Series B cash flow reinvestment rate. Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Cash Flow Reinvestment Rate of 1.15x as of December 2020, reinvesting Skr239.00K (capex Skr30.00K plus investments Skr-209.00K) from operating cash flow of Skr207.00K. Explore cash flow to debt ratio of Scandinavian ChemoTech AB Series B to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Scandinavian ChemoTech AB Series B Cash Flow Reinvestment Rate by Year (None–None)
Scandinavian ChemoTech AB Series B cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Scandinavian ChemoTech AB Series B. For the full cash flow conversion analysis, see cash efficiency ratio of Scandinavian ChemoTech AB Series B.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|